Breau RH, Kokolo MB, Punjani N, Cagiannos I, Beck A, Niznick N, Buenaventura C, Cowan J, Knoll G, Momoli F, Morash C, Ruzicka M, Schachinka S, Tinmouth A, Xie HY, and Fergusson DA. Efficacy and safety of lysine analogs during pelvic surgery: a systematic review. Transfusion Medicine Reviews. 2014. In Press.

Lavallée LT, Fergusson D, Mallick R, Grenon R, Morgan SC, Momoli F, Witiuk K, Morash C, Cagiannos I, and Breau RH. Radiotherapy after Radical Prostatectomy: Treatment Recommendations Differ between Urologists and Radiation Oncologists. PLoS ONE 8(11): e79773. doi:10.1371/journal.pone.0079773. Nov 4, 2013.

Punjani N, Lavallée LT, Momoli F, Fergusson D, Witiuk K, Mallick R, Morash C, Cagiannos I, and Breau RH. Blood Transfusion and Hemostatic Agents used during Radical Cystectomy. Canadian Urological Association Journal 2013; 7(5-6):e275-80. http://dx.doi.org/10.5489/cuaj.1002 Published online May 13, 2013.

Breau RH, Karnes RJ, Jacobson DJ, McGree ME, Jacobsen SJ, Nehra A, Lieber MM, and St. Sauver JL. The association between statin use and the diagnosis of prostate cancer. J. Urol. 2010 184(2): 494-9.

Breau RH, Crispen PL, Jimenez RE, Lohse CM, Blute ML, and Leibovich BC. Outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy. J Urol. 2010 Mar;183(3):903-8.

All Other Publications

Bachir B, Dragomir A, Aprikian A, Tanguay S, Fairey A, Kulkarni G, Breau RH, Black P, and Kassouf W. Contemporary cost-effectiveness analysis comparing sequential BCG and electromotive mitomycin versus BCG alone for patients with high-risk non-muscle invasive bladder cancer. CNCR-14-0081.R1. 2014.

Malone SC, Haridass A, Nyiri B, Croke J, Malone C, Breau RH, Morash C, Avruch L, Daneshmand M, Malone K, Delatour NR, Ahmed I, and Belanger E. Creation of 3-dimensional prostate cancer maps: methodology and clinical and research implications. Arch Pathol Lab Med. 2014 Jun; 138(6): 803-8. doi. 10.5858/arpa.2012-0609-OA.

Nair VJ, Szanto J, Vandervoort E, Cagiannos I, Breau RH, Malone C, Avruch L, Pantarotto J, and Malone S. CyberKnife for inoperable renal tumors: Canadian pioneering experience. Can J Urol. 2013 Oct;20(5):6944-9.

Breau RH, Karnes R, Farmer S, Thapa P, Cagiannos I, Morash C, and Frank I. Progression to detrusor muscle invasion during Urothelial carcinoma surveillance is associated with poor prognosis. BJU Int. 2013 Aug 12. doi: 10.1111/bju.12403.

North S, Basappa N, Bjarnason G, Blais N, Canil C, Heng D, Knox J, Reaume N, Ruether D, Soulieres D, Zalewski P, Black P, Breau RH, Jewett M, Kapoor A, Lattouf JB, Moore R, Rendon R, Todd G, Pituskin E, Gedye C, and Wood L. Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013. Canadian Urological Association Journal = Journal de l'Association des urologues du Canada, 7(7-8).

Lee TK, Breau RH, and Eapen L. Pilot Study on Quality of Life and Sexual Function in Men-Who-Have-Sex-with-Men Treated for Prostate Cancer. J Sex Med. 2013 Jun 6. doi: 10.1111/jsm.12208.

Breau RH, Clark E, Bruner B, Cervini P, Atwell T, Knoll G, and Leibovich BC. A Simple Method to Estimate Renal Volume From Computed Tomography. Canadian Urological Association Journal 2013; 7(5-6):189-92. http://dx.doi.org/10.5489/cuaj.1338.

Bell MD, Lavallée LT, Dahm P, Witiuk K, and Breau RH. Diagnostic tests in urology: percutaneous biopsy of renal masses. BJU Int. 2013 Feb;111(2):362-4. doi: 10.1111/j.1464-410X.2012.11440.x. No abstract available. Erratum in: BJU Int. 2013 May;111(5):852.

Preston MA, Harisinghani MG, Mucci L, Witiuk K, and Breau RH. Diagnostic tests in urology: magnetic resonance imaging (MRI) for the staging of prostate cancer. BJU Int. 2013 Mar;111(3):514-7. doi: 10.1111/j.1464-410X.2012.11447.x. Epub 2013 Jan 15.

Weight CJ, Crispen PL, Breau RH, Kim SP, Lohse CM, Boorjian SA, Thompson RH, Leibovich BC. Practice-setting and surgeon characteristics heavily influence the decision to perform partial nephrectomy among American Urologic Association surgeons. BJU Int. 2012 Apr 13. doi: 10.1111/j.1464-410X.2012.11112.x. [Epub ahead of print] PubMed PMID: 22502641.

Lavallée LT, Desantis D, Kamal F, Blew B, Watterson J, Mallick R, Fergusson D, Morash C, Cagiannos I, and Breau RH. The association between renal tumour scoring systems and ischemia time during open partial nephrectomy. Can Urol Assoc J. 2012 May 15:1-8. doi: 10.5489/cuaj.11202. [Epub ahead of print] PubMed PMID: 22630339.

Rodrigues G, Yao X, Loblaw A, Brundage M, Chin J, Genitourinary Cancer Disease Site Group. Low-dose rate brachytherapy for patients with low- or intermediate-risk prostate cancer. Toronto, ON: Cancer Care Ontario; 2012 Oct 31. Program in Evidence-based Care Evidence-Based Series No.: 3-10 Version 2.

Yi Y, Breau RH, Witiuk K, Neuberger MM, and Dahm P. Diagnostic tests in urology: percentage of free prostate-specific antigen (PSA). BJU Int. 2013 Apr;111(4):683-5. doi: 10.1111/j.1464-410X.2012.11446.x. Epub 2012 Oct 29. Review.

Lavallée LT, Fergusson D, Dahm P, Scales CD Jr, Witiuk K, and Breau RH. Diagnostic tests in urology: urine cytology. BJU Int. 2012 Dec;110(11 Pt C):E789-91. doi: 10.1111/j.1464-410X.2012.11448.x. Epub 2012 Oct 26.

Breau RH, Scales CD Jr, and Dahm P; International Evidence Based Urology Working Group. Diagnostic tests in urology: an introduction. BJU Int. 2012 Dec;110(11 Pt C):E792-3. doi: 10.1111/j.1464-410X.2012.11449.x. Epub 2012 Oct 26.

Lavallee LT, Breau RH, Preston MA, Raju G, Morash C, Doucette S, Gerridzen RG, Eastham J, and Cagiannos I. The association between tumour density and prostate cancer recurrence following radical prostatectomy. Can Urol Assoc J. 2011 Dec;5(6):397-401.

Preston M, Fergusson DA, and Breau RH. Appraisal and use of a prognostic study from the urological literature. Indian J Urol. 2011 Oct;27(4):508-12. PubMed PMID: 22279320; PubMed Central PMCID: PMC3263222.

Lavallée LT, Montori VM, Canfield SE, and Breau RH. Advanced topics in evidence-based urologic oncology: surrogate endpoints. Urol Oncol. 2011 Jul-Aug;29(4):447-53.

Lavallee LT, Fergusson D, and Breau RH. The role of randomized controlled trials in evidence-based urology. World J Urol. 2011 Jun;29(3):257-63.

Breau RH, Crispen PL, Jenkins SM, Blute ML, and Leibovich BC. Treatment of patients with small renal masses: a survey of the American Urological Association. J Urol 2011 Feb;185(2):407-13.

Breau RH, Clark AT, Morash C, Fergusson D, and Cagiannos I. Associations between radiographic characteristics and change in renal function following partial nephrectomy using 24-hour creatinine clearance. Can Urol Assoc J. 2011 Feb; 5(1):45-8.

Crispen PL, Breau RH, Allmer C, Lohse CM, Cheville JC, Leibovich BC, and Blute ML. Lymph node dissection at the time of radical nephrectomy for high-risk clear cell renal cell carcinoma: Indications and recommendations for surgical templates. Eur Urol. 2011 Jan;59(1):18-23.

Bruner B, Breau RH, Lohse CM, Leibovich BC, and Blute ML. Renal nephrectomy score is associated with urine leak after partial nephrectomy. BJU Int 2010 Nov 18.

Childs MA, Breau RH, Umbreit EC, Lohse CM, Cheville JC, Thompson RH, Blute ML, and Leibovich BC. Metachronous renal tumours after surgical management of oncocytoma. BJU Int. 2010 Nov 18.

Crispen PL, Tabidian MR, Allmer C, Lohse CM, Breau RH, Blute ML, Cheville JC, and Leibovich BC. Unclassified renal cell carcinoma: impact on survival following nephrectomy. Urology 2010 Sep;76(3):580-6.

Kim B, Breau RH, Papadatos D, Fergusson D, Cagiannos I, and Morash C. Diagnostic accuracy of surface coil magnetic resonance imaging at 1.5T for local staging of elevated risk prostate cancer. Can Urol Assoc J. 2010 Aug;4(4):257-62.

Preston MA, Blew BD, Breau RH, Beiko D, Oake SJ, and Watterson JD. Survey of senior resident training in urologic laparoscopy, robotics and endourology surgery in Canada. Can Urol Assoc J. 2010 Feb; 4(1):42-6.

Breau RH, Fergusson D, and Dahm P. Evidence-based urology in practice: number needed to treat. BJU Int. 2009 Jul;104(1):6-8.

Tseng TY, Breau RH, Fesperman SF, Vieweg J, and Dahm P. Evaluating the evidence: the methodological and reporting quality of comparative observational studies of surgical interventions in urological publications. BJU Int. 2009 Apr;103(8):1026-31.

Breau RH, Dahm P, Fergusson DA, and Hatala R. Understanding results. J Urol. 2009 Mar;181(3):985-92.

Clark AT, Breau RH, Morash C, Fergusson D, Doucette S, and Cagiannos I. Preservation of renal function following partial or radical nephrectomy using 24-hour creatinine clearance. Eur Urol. 2008 Jul;54(1):143-49.

Taylor JS, Breau RH, Cagiannos I, and Morash C. Renal sarcoma and associated malignant pulmonary embolism: a report of 2 cases. Can Urol Assoc J. 2007 Jun;1(2):123-5.

Breau RH, Carnat TA, and Gaboury I. Inadequate statistical power of negative clinical trials in urological literature. J Urol. 2006 Jul;176(1):263-6.

Murray SK, Breau RH, Guha AK, and Gupta R. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma. Am J Surg Pathol. 2004 Sep;28(9):1154-62.

Breau RH, McGrath PJ, and Norman RW. Assessing self-help issues for patients with prostate cancer, interstitial cystitis, erectile dysfunction and urinary diversion. BJU Int. 2003 Nov;92(7):736-40.

Breau RH, and Norman RW. The role of self-help groups in educating and supporting patients with prostate cancer and interstitial cystitis. BJU Int. 2003 Oct;92(6):602-6.

Norman RW, and Breau RH. Optimal length of ureteric stents. Clin Radiol. 2003 Mar;58(3):257.

Breau RH, and Norman RW. Optimal prevention and management of proximal ureteral stent migration and remigration. J Urol. 2001 Sep;166(3):890-3.